Related Experiment Video
Updated: Jul 14, 2026

Antibiotic Dereplication Using the Antibiotic Resistance Platform
Published on: October 17, 2019
Chloramphenicol is a substrate for a novel nitroreductase pathway in Haemophilus influenzae
Arnold L Smith1, Alice L Erwin, Toni Kline
1Microbial Pathogens Program, Seattle Biomedical Research Institute, Seattle, WA 98109-5219, USA. arnold.smith@sbri.org
Abstract:
The p-nitroaromatic antibiotic chloramphenicol has been used extensively to treat life-threatening infections due to Haemophilus influenzae and Neisseria meningitidis; its mechanism of action is the inhibition of protein synthesis. We found that during incubation with H. influenzae cells and lysates, chloramphenicol is converted to a 4-aminophenyl allylic alcohol that lacks antibacterial activity. The allylic alcohol moiety undergoes facile re-addition of water to restore the 1,3-diol, as well as further dehydration driven by the aromatic amine to form the iminoquinone. Several Neisseria species and most chloramphenicol-susceptible Haemophilus species, but not Escherichia coli or other gram-negative or gram-positive bacteria we examined, were also found to metabolize chloramphenicol. The products of chloramphenicol metabolism by species other than H. influenzae have not yet been characterized. The strains reducing the antibiotic were chloramphenicol susceptible, indicating that the pathway does not appear to mediate chloramphenicol resistance. The role of this novel nitroreductase pathway in the physiology of H. influenzae and Neisseria species is unknown. Further understanding of the H. influenzae chloramphenicol reduction pathway will contribute to our knowledge of the diversity of prokaryotic nitroreductase mechanisms.
Insights
Chloramphenicol is metabolized by Haemophilus influenzae and Neisseria species into inactive compounds, a process not linked to antibiotic resistance. This nitroreductase pathway
Area of Science:
- Microbiology
- Biochemistry
- Antibiotic Resistance
Background:
- Chloramphenicol is a vital antibiotic for treating serious infections caused by Haemophilus influenzae and Neisseria meningitidis.
- Its mechanism involves inhibiting bacterial protein synthesis.
Purpose of the Study:
- To investigate the metabolic fate of chloramphenicol in H. influenzae and related bacteria.
- To characterize the products of chloramphenicol metabolism and assess their impact on antibiotic resistance.
Main Methods:
- Incubation of chloramphenicol with H. influenzae cells and lysates.
- Analysis of metabolic products using biochemical techniques.
- Testing chloramphenicol susceptibility in bacterial strains that metabolize the antibiotic.
Main Results:
- Chloramphenicol is converted to a 4-aminophenyl allylic alcohol, which lacks antibacterial activity.
- This alcohol can revert to the 1,3-diol or dehydrate to form an iminoquinone.
- Metabolism occurs in Neisseria species and susceptible Haemophilus species, but not in E. coli or other tested bacteria.
- The identified metabolic pathway does not confer chloramphenicol resistance.
Conclusions:
- A novel nitroreductase pathway metabolizes chloramphenicol in H. influenzae and Neisseria species.
- This pathway inactivates the antibiotic without mediating resistance.
- Further research is needed to understand the physiological role of this pathway and the diversity of prokaryotic nitroreductase mechanisms.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Production of Antibiotics
Antibiotic Selection
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis
Inorganic Nitrogen Assimilation
